Martin Hellmich Selected Research

gadoterate meglumine

1/2022	Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
12/2019	Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Hellmich Research Topics

Disease

24	Neoplasms (Cancer) 04/2022 - 02/2004
8	Heart Failure 12/2021 - 08/2006
7	Schizophrenia (Dementia Praecox) 01/2022 - 04/2009
7	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2007
7	Infections 01/2020 - 07/2011
6	Heart Arrest (Cardiac Arrest) 04/2022 - 06/2012
6	Sepsis (Septicemia) 02/2020 - 01/2014
6	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 08/2007
5	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 08/2006
5	Myocardial Infarction 01/2019 - 10/2012
4	Out-of-Hospital Cardiac Arrest 02/2022 - 06/2012
4	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2009
4	Atrial Fibrillation 07/2015 - 08/2006
3	Pulmonary Arterial Hypertension 10/2022 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 02/2010
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2021 - 09/2019
3	Multiple Myeloma 01/2021 - 02/2004
3	Hypertension (High Blood Pressure) 01/2021 - 08/2006
3	Coronary Disease (Coronary Heart Disease) 12/2020 - 05/2007
3	Atherosclerosis 11/2020 - 10/2012
3	Prodromal Symptoms 01/2019 - 04/2009
3	Acute Kidney Injury (Acute Renal Failure) 12/2018 - 07/2012
3	Critical Illness (Critically Ill) 07/2016 - 01/2015
3	Cardiogenic Shock 02/2016 - 06/2012
3	Type 2 Diabetes Mellitus (MODY) 06/2015 - 02/2010
2	COVID-19 06/2022 - 01/2022
2	Multiple Sclerosis 01/2022 - 01/2010
2	Dystonia (Limb Dystonia) 01/2022 - 05/2013
2	Cerebral Palsy (Spastic Diplegia) 01/2022 - 05/2013
2	Iron Deficiencies 12/2021 - 09/2013
2	Pain (Aches) 10/2021 - 03/2014
2	Wounds and Injuries (Trauma) 04/2021 - 03/2015
2	Fibrosis (Cirrhosis) 04/2021 - 09/2011
2	Lymphoma (Lymphomas) 01/2021 - 01/2016
2	Liver Diseases (Liver Disease) 01/2021 - 02/2020
2	Bacteremia 02/2020 - 07/2011
2	Foreign Bodies (Foreign Body) 02/2020 - 05/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2014
2	Dementia (Dementias) 01/2020 - 06/2009
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2019 - 06/2009
2	Retinal Detachment (Retinal Detachments) 11/2018 - 01/2017
2	Mental Disorders (Mental Disorder) 01/2018 - 06/2009
2	AIDS-Related Complex (ARC) 12/2017 - 08/2014
2	Reperfusion Injury 01/2017 - 07/2015
2	Dyspnea (Shortness of Breath) 11/2016 - 09/2011
2	Hemorrhage 07/2016 - 06/2011
2	ST Elevation Myocardial Infarction 02/2016 - 01/2015
2	Ischemia 07/2015 - 07/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 05/2011
2	Neutropenia 12/2014 - 12/2011

Drug/Important Bio-Agent (IBA)

7	anandamide (arachidonylethanolamide)IBA 01/2021 - 08/2007
6	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2014
4	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 03/2008
4	Biomarkers (Surrogate Marker)IBA 08/2020 - 03/2005
4	oleoylethanolamideIBA 01/2019 - 03/2009
4	DNA (Deoxyribonucleic Acid)IBA 04/2017 - 04/2012
3	AntigensIBA 01/2022 - 02/2004
3	Biological ProductsIBA 12/2021 - 01/2015
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 04/2021 - 01/2018
3	CreatinineIBA 01/2021 - 07/2012
3	CalciumIBA 11/2020 - 12/2017
3	EndocannabinoidsIBA 01/2019 - 04/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2005
3	Glucose (Dextrose)FDA LinkGeneric 03/2014 - 02/2010
2	gadoterate meglumineIBA 01/2022 - 12/2019
2	GadoliniumIBA 01/2022 - 12/2019
2	EnzymesIBA 01/2022 - 12/2013
2	salicylhydroxamic acid (SHAM)IBA 09/2021 - 07/2012
2	CannabidiolIBA 01/2021 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2020 - 06/2015
2	Antipsychotic Agents (Antipsychotics)IBA 12/2019 - 06/2009
2	PlatinumIBA 09/2019 - 08/2018
2	Bevacizumab (Avastin)FDA Link 05/2019 - 08/2018
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 02/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017 - 07/2015
2	LipidsIBA 12/2017 - 08/2014
2	Morphine (MS Contin)FDA LinkGeneric 11/2016 - 01/2005
2	esmolol (Brevibloc)FDA LinkGeneric 02/2016 - 01/2015

Therapy/Procedure

31	Therapeutics 10/2022 - 01/2005
9	Drug Therapy (Chemotherapy) 04/2021 - 06/2007
6	Palliative Care (Palliative Therapy) 01/2022 - 06/2010
5	Induced Hypothermia 04/2022 - 06/2012
5	Resuscitation 11/2020 - 06/2012
3	Cardiopulmonary Resuscitation (CPR) 04/2022 - 12/2018
3	Mastectomy (Mammectomy) 01/2022 - 06/2018
3	Deep Brain Stimulation 01/2022 - 05/2013
3	Lymph Node Excision (Lymph Node Dissection) 04/2021 - 06/2018
3	Length of Stay 01/2020 - 07/2015
3	Operative Surgical Procedures 12/2019 - 06/2011
3	Catheters 01/2015 - 01/2014
2	Endurance Training 10/2021 - 03/2021
2	Radiotherapy 01/2021 - 06/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 07/2016
2	Mammaplasty (Breast Reconstruction) 12/2019 - 06/2018
2	Corneal Transplantation (Keratoplasty) 05/2019 - 01/2017
2	Vitrectomy 11/2018 - 01/2017
2	Percutaneous Coronary Intervention 12/2017 - 05/2015
2	Critical Care (Surgical Intensive Care) 07/2016 - 12/2011
2	Chemoradiotherapy 01/2016 - 04/2011
2	Central Venous Catheters 01/2015 - 01/2015